Kuansheng Ma

3.5k total citations · 1 hit paper
97 papers, 2.0k citations indexed

About

Kuansheng Ma is a scholar working on Hepatology, Surgery and Epidemiology. According to data from OpenAlex, Kuansheng Ma has authored 97 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 70 papers in Hepatology, 43 papers in Surgery and 39 papers in Epidemiology. Recurrent topics in Kuansheng Ma's work include Hepatocellular Carcinoma Treatment and Prognosis (66 papers), Liver Disease Diagnosis and Treatment (33 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (26 papers). Kuansheng Ma is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (66 papers), Liver Disease Diagnosis and Treatment (33 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (26 papers). Kuansheng Ma collaborates with scholars based in China, Sweden and Hong Kong. Kuansheng Ma's co-authors include Ping Bie, X Y Feng, Xiaowu Li, Kai Feng, Shuguang Wang, Jiahong Dong, Jun Yan, Xiaochu Yan, Chunlin Tang and Deyu Guo and has published in prestigious journals such as PLoS ONE, Scientific Reports and Journal of Hepatology.

In The Last Decade

Kuansheng Ma

87 papers receiving 2.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A randomized controlled trial of radiofrequency ablation and surgical resection in the treatment of small hepatocellular carcinoma

2012 551 citations Kai Feng, Jun Yan et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kuansheng Ma China	24	1.5k	930	704	395	333	97	2.0k
Ya-Qi Zhang China	13	2.2k 1.5×	1.3k 1.4×	905 1.3×	411 1.0×	352 1.1×	16	2.5k
Jin-Qing Li China	15	2.0k 1.3×	1.2k 1.2×	835 1.2×	460 1.2×	298 0.9×	21	2.3k
Ryuichi Kita Japan	25	1.3k 0.9×	923 1.0×	370 0.5×	359 0.9×	198 0.6×	76	1.8k
Yukihiro Koike Japan	14	1.9k 1.3×	1.3k 1.4×	473 0.7×	251 0.6×	256 0.8×	31	2.2k
Wai‐Kuen Tso Hong Kong	12	2.6k 1.8×	1.1k 1.2×	931 1.3×	349 0.9×	554 1.7×	14	2.9k
Delia D’Avola Spain	25	1.2k 0.8×	726 0.8×	489 0.7×	407 1.0×	326 1.0×	60	2.1k
Azusa Kitao Japan	29	1.6k 1.1×	1.4k 1.5×	814 1.2×	289 0.7×	279 0.8×	60	2.6k
Lai Mun Wang United Kingdom	26	510 0.3×	748 0.8×	651 0.9×	1.1k 2.8×	505 1.5×	84	2.4k
Ruhai Zou China	19	783 0.5×	380 0.4×	358 0.5×	247 0.6×	212 0.6×	45	1.3k
Zhenlin Yan China	20	714 0.5×	428 0.5×	954 1.4×	697 1.8×	678 2.0×	36	1.9k

Countries citing papers authored by Kuansheng Ma

Since Specialization

Citations

This map shows the geographic impact of Kuansheng Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kuansheng Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kuansheng Ma more than expected).

Fields of papers citing papers by Kuansheng Ma

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kuansheng Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kuansheng Ma. The network helps show where Kuansheng Ma may publish in the future.

Co-authorship network of co-authors of Kuansheng Ma

This figure shows the co-authorship network connecting the top 25 collaborators of Kuansheng Ma. A scholar is included among the top collaborators of Kuansheng Ma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kuansheng Ma. Kuansheng Ma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Song, Ju‐Xian, Li Cao, Kuansheng Ma, et al.. (2024). Laparoscopic liver resection versus radiofrequency ablation for small hepatocellular carcinoma: randomized clinical trial. British journal of surgery. 111(4). 4 indexed citations

Meng, Zhaowei, Yongxian Guo, Shengming Deng, et al.. (2024). Improving image quality of triple-low-protocol renal artery CT angiography with deep-learning image reconstruction: a comparative study with standard-dose single-energy and dual-energy CT with adaptive statistical iterative reconstruction. Clinical Radiology. 79(5). e651–e658. 2 indexed citations

Li, Changfeng, Qiang Wang, Ping Cai, et al.. (2023). A radiomics model based on preoperative gadoxetic acid–enhanced magnetic resonance imaging for predicting post-hepatectomy liver failure in patients with hepatocellular carcinoma. Frontiers in Oncology. 13. 1164739–1164739. 3 indexed citations

Wang, Qiang, Changfeng Li, Kai Feng, et al.. (2023). Unsupervised Machine Learning of MRI Radiomics Features Identifies Two Distinct Subgroups with Different Liver Function Reserve and Risks of Post-Hepatectomy Liver Failure in Patients with Hepatocellular Carcinoma. Cancers. 15(12). 3197–3197. 5 indexed citations

Wang, Qiang, Torkel B. Brismar, Shu Chen, et al.. (2021). Sequential Portal Vein Embolization and Percutaneous Radiofrequency Ablation for Future Liver Remnant Growth: A Minimally Invasive Alternative to ALPPS Stage-1 in Treatment of Hepatocellular Carcinoma. Frontiers in Surgery. 8. 741352–741352. 2 indexed citations

Chen, Shihan, Kun Li, Xiaofei Wang, et al.. (2020). Low expression of organic anion-transporting polypeptide 1B3 predicts a poor prognosis in hepatocellular carcinoma. World Journal of Surgical Oncology. 18(1). 127–127. 15 indexed citations

Chen, Geng, et al.. (2019). Simultaneous super-selective hepatic arterial and portal vein embolization for staged hepatectomy in patients with hepatocellular carcinoma and cirrhosis. Zhonghua gan-dan waike zazhi. 25(4). 249–253.

He, Xiaoning, Jing Wu, Anke‐Peggy Holtorf, et al.. (2018). Health economic assessment of Gd-EOB-DTPA MRI versus ECCM-MRI and multi-detector CT for diagnosis of hepatocellular carcinoma in China. PLoS ONE. 13(1). e0191095–e0191095. 11 indexed citations

Li, Rui, Dan Yang, Chunlin Tang, et al.. (2016). Combined hepatocellular carcinoma and cholangiocarcinoma (biphenotypic) tumors: clinical characteristics, imaging features of contrast-enhanced ultrasound and computed tomography. BMC Cancer. 16(1). 158–158. 77 indexed citations

10.

Li, Rui, et al.. (2016). Dynamic enhancement patterns of intrahepatic cholangiocarcinoma in cirrhosis on contrast-enhanced computed tomography: risk of misdiagnosis as hepatocellular carcinoma. Scientific Reports. 6(1). 26772–26772. 27 indexed citations

11.

Feng, Xiaobin, Ruocai Xu, Xilin Du, et al.. (2014). Combination Therapy With Sorafenib and Radiofrequency Ablation for BCLC Stage 0–B1 Hepatocellular Carcinoma: A Multicenter Retrospective Cohort Study. The American Journal of Gastroenterology. 109(12). 1891–1899. 59 indexed citations

12.

Feng, X Y, Lin Wu, W. Y. Lau, et al.. (2014). Positive Lymph Node Metastasis Has a Marked Impact on the Long-Term Survival of Patients with Hepatocellular Carcinoma with Extrahepatic Metastasis. PLoS ONE. 9(4). e95889–e95889. 33 indexed citations

13.

Feng, X Y, Guo Li, W. Y. Lau, Kuansheng Ma, & Ping Bie. (2014). Intrahepatic Glissonian approach and outflow vascular occlusion during partial hepatectomy. Hepatobiliary & pancreatic diseases international. 13(1). 101–104. 4 indexed citations

14.

Li, Rui, Kuansheng Ma, Xiaowu Li, et al.. (2014). Detailed Analysis of Temporal Features on Contrast Enhanced Ultrasound May Help Differentiate Intrahepatic Cholangiocarcinoma from Hepatocellular Carcinoma in Cirrhosis. PLoS ONE. 9(5). e98612–e98612. 56 indexed citations

15.

Duan, Chenyang, et al.. (2013). Radiofrequency ablation versus hepatic resection for the treatment of early-stage hepatocellular carcinoma meeting Milan criteria: a systematic review and meta-analysis. World Journal of Surgical Oncology. 11(1). 190–190. 56 indexed citations

16.

Zhu, Jin, Kuansheng Ma, Kai Feng, et al.. (2013). Autologous bone marrow-derived mesenchymal stem cell transplantation promotes liver regeneration after portal vein embolization in cirrhotic rats. Journal of Surgical Research. 184(2). 1161–1173. 35 indexed citations

17.

Gao, Jun, Yongkang Liu, Kai Feng, et al.. (2012). Determining a minimal safe distance to prevent thermal injury to intrahepatic bile ducts in radiofrequency ablation of the liver: A study in dogs. International Journal of Hyperthermia. 28(3). 210–217. 14 indexed citations

18.

Yan, Jun, Qian Lü, Jiahong Dong, et al.. (2012). Hepatitis B virus X protein suppresses caveolin-1 expression in hepatocellular carcinoma by regulating DNA methylation. BMC Cancer. 12(1). 353–353. 14 indexed citations

19.

Liu, Quanda, Kuansheng Ma, Yang Song, Ningxin Zhou, & Zhenping He. (2008). Two-year follow-up of splenic radiofrequency ablation in patients with cirrhotic hypersplenism: Does increased hepatic arterial flow induce liver regeneration?. Surgery. 143(4). 509–518. 18 indexed citations

20.

Ma, Kuansheng, et al.. (2003). Preoperative selective portal vein embolization in two-step hepatectomy for hepatocellular carcinoma in injured livers: a preliminary report.. PubMed. 2(2). 216–20. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact